Detalles de la búsqueda
1.
Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients.
Int J Mol Sci
; 24(17)2023 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686312
2.
Traditional Clinicopathological Biomarkers Still Determine Disease-Free and Overall Survival in Invasive Breast Cancer Patients: A Pilot Study.
J Clin Med
; 13(7)2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38610786
3.
Hypercoagulability State Combined with Post-Treatment Hypofibrinolysis in Invasive Breast Cancer: A Seven-Year Follow-Up Evaluating Disease-Free and Overall Survival.
Life (Basel)
; 13(5)2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37240751
4.
High Post-Treatment Leptin Concentration as a Prognostic Biomarker of the High Risk of Luminal Breast Cancer Relapse: A Six-Year Comprehensive Study.
Life (Basel)
; 12(12)2022 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36556428
5.
Tissue Plasminogen Activator as a Possible Indicator of Breast Cancer Relapse: A Preliminary, Prospective Study.
J Clin Med
; 11(9)2022 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35566525
Resultados
1 -
5
de 5
1
Próxima >
>>